Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 0615-8084

5 FDA label images from Ncs Healthcare Of Ky, Llc Dba Vangard Labs · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 0615-8084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Cyclobenzaprine Tabs 10 mg 8084 1)

Image (Cyclobenzaprine Tabs 10 mg 8084 1)
Chemical structure of Cyclobenzaprine Hydrochloride, showing the tricyclic ring system and attached functional groups, including the hydrochloride component.*
FDA Label Image

Image (Cyclobenzaprine Tabs 10 mg 8084 2)

Image (Cyclobenzaprine Tabs 10 mg 8084 2)
A data table presenting the incidence percentages of four side effects — drowsiness, dry mouth, fatigue, and headache — in clinical groups taking Cyclobenzaprine HCl tablets at 5 mg and 10 mg doses, compared to a placebo group. The table lists the number of participants in each group along with corresponding side effect rates.*
FDA Label Image

Image (Cyclobenzaprine Tabs 10 mg 8084 3)

Image (Cyclobenzaprine Tabs 10 mg 8084 3)
A data table comparing the incidence of drowsiness, dry mouth, and dizziness reported in clinical studies versus a surveillance program for Cyclobenzaprine Hydrochloride 10 mg tablets.*
FDA Label Image

Principal Display Panel (Cyclobenzaprine Tabs 10 mg 8084 4)

Principal Display Panel (Cyclobenzaprine Tabs 10 mg 8084 4)
Label for Cyclobenzaprine Hydrochloride Tablets USP 10 mg, film-coated oral tablets. The label shows packaging for a quantity of 30 tablets manufactured by Invagen for Cipla and packaged by Vanguard Labs, Glasgow, KY 42141. It includes multiple barcodes, lot number 8084, and instructions indicating institutional use only, storage at 20° to 25°C, and reference to a package insert for full prescribing information.*
FDA Label Image

Principal Display Panel (Cyclobenzaprine Tabs 10 mg 8084 5)

Principal Display Panel (Cyclobenzaprine Tabs 10 mg 8084 5)
Label sheet for Cyclobenzaprine Hydrochloride Tablets USP 10 mg by NCS HealthCare of KY, LLC dba Vangard Labs. The sheet includes multiple identical small labels each stating "Cyclobenzaprine HCl Tab USP 10 mg" with lot number 8084 and a barcode. Below is a larger label with detailed information including quantity 30 tablets, storage instructions, Rx only designation, and manufacturing and repackaging details by Invagen for Cipla and Vangard Labs in Glasgow, KY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.